The administration of 120 mg of orlistat three times daily with a hypocaloric diet for 16 weeks promoted weight loss in obese alcoholic fatty liver patients compared to the control, with significantly improved insulin sensitivity and liver enzymes. This evidence concerns the gene INS and Hepatic steatosis.